- Tech Stock Insider
- Posts
- Domain Provider Seeks to Double Shares Again in 2025
Domain Provider Seeks to Double Shares Again in 2025
Hello and welcome to the Tech Stock Insider, the twice-weekly newsletter covering the biggest opportunities in the tech world.
Today, we’ll look into the latest tech news, highlight some recent movers, and investigate an under-the-radar tech stock with potential.

AI
Electricity reshaped the economy, creating the FAANG stocks and boosting GDP by over 4,900%. AI is going to do it again. Here's what to buy...

Software
Salesforce Challenges Veeva in Fight for Pharma Software Market
Salesforce is intensifying its competition with Veeva Systems by targeting pharmaceutical companies with its soon-to-launch life sciences software. Historically, Veeva dominated this niche, offering customer relationship management tools built on Salesforce's platform. However, Veeva’s decision to end its agreement with Salesforce in 2022 opened the door for the latter to create a competing product.
Salesforce has reportedly secured agreements with over 40 customers for its upcoming solution, including several transitioning from Veeva. This marks a significant shift in the competitive landscape, as Salesforce seeks to carve out a space in an industry where its core offerings aren’t yet widely adopted. The company is accelerating development efforts and engaging with major pharmaceutical firms to establish a foothold.
Meanwhile, Veeva is working on rebuilding its CRM product independently, leveraging its long-standing expertise in the life sciences sector. Despite the competitive pressure, Veeva anticipates retaining the majority of its clients, with some of its largest customers reaffirming their commitment.
This rivalry underscores Salesforce’s broader strategy to fuel growth by expanding into underpenetrated markets while enhancing its portfolio with AI-driven tools and data integration capabilities. The unfolding battle between these two players highlights the growing demand for specialized solutions in the pharmaceutical industry.

Software
Netflix Files Patent Lawsuit Against Broadcom Over Virtual Machine Technology

Netflix has initiated legal action against Broadcom, alleging that the chipmaker's VMware subsidiary has infringed on its patents related to virtual machine technology. Filed in a California federal court, the lawsuit centers on VMware’s vSphere platform, a tool used for managing virtual machines, which Netflix claims violates several of its patents tied to virtual-machine operations.
This legal dispute adds a new chapter to the ongoing tensions between Netflix and Broadcom, which have been engaged in a separate patent battle since 2018. That case focuses on alleged infringements by Netflix concerning Broadcom’s video streaming technology, with trials scheduled across multiple jurisdictions, including the United States and Europe.
Netflix is seeking financial compensation for the alleged patent violations, though the specific amount has not been disclosed. Broadcom, which acquired VMware in 2022, has not yet provided a response to these allegations.
This lawsuit highlights the increasing complexities in intellectual property disputes as technology companies expand into overlapping domains. Both Netflix and Broadcom continue to navigate a challenging legal landscape as they defend their innovations and market positions.

Search Engines
Apple Seeks Role in Google Antitrust Trial Over Search Engine Deals

Apple has requested to participate in Google’s upcoming U.S. antitrust trial, arguing that it can no longer rely on Google to defend the substantial revenue-sharing agreements that bring billions to Apple each year from making Google the default search engine on Safari. Despite this, Apple has no plans to develop its own search engine to compete with Google, regardless of the outcome of the case.
Apple's legal team has expressed that Google is no longer in a position to adequately represent its interests, especially with the trial set to address efforts to break up Google's business units. As a result, Apple intends to call witnesses to testify at the April trial. This landmark case, led by the Department of Justice, could have far-reaching consequences for the future of online search.
Google has proposed some changes to its default agreements with device makers and carriers but intends to keep its revenue-sharing arrangements intact. The trial could ultimately reshape how search engines are integrated into devices and browsers, impacting the way users access online information.


Recent Tech Movers
Godaddy Inc (GDDY) is a domain hosting and web-building site with a slew of tools to help businesses grow. Its shares have more than doubled since the beginning of the year.
GigaCloud Technology (GCT) boasted strong earnings growth over the past year, and forecasts show more of the same in 2025. Its B2B e-commerce solutions could also reach more industries in the U.S. and beyond.
Clene Inc (CLNN) is still a clinical-stage biotech firm, but its work on neurodegenerative diseases appears very promising. We haven’t seen much in the way of share increases yet, but its revenue and earnings growth seem to indicate positive movement on the horizon.

Don’t Overlook This Tech Stock
Gitlab Inc (GTLB) is a DevSecOps platform that started as an open-source project by a small team of developers back in 2011. It’s grown to host millions of programmers and their initiatives, helping them deliver software faster and with fewer bugs along the way. Shares haven’t done much for investors in 2024, but the company’s perfectly positioned to help build out many AI platforms other businesses need to survive in this new climate.


Everything Else
AI and cryptocurrency played a major role in the rise of this year’s five biggest tech stocks.
Duos Tech reached its 52-week high this week as the company celebrates historic growth.
Digital Wave Technology made news as a vendor to watch in the IDC MarketScape for Worldwide Retail Promotions Management.
Micron Technology suffered a price target cut, but the company’s future still looks promising.
Several up-and-coming military tech firms seek to usurp Lockheed Martin’s dominance in the sector.

That's our coverage for today; thanks for reading! Reply to this email with feedback or any tech stocks you want me to check out.
Best Regards,
—Noah Zelvis
Tech Stock Insider